US Stock MarketDetailed Quotes

DNA Ginkgo Bioworks

Watchlist
  • 14.730
  • +1.180+8.71%
Close Feb 14 16:00 ET
  • 14.690
  • -0.040-0.27%
Post 20:01 ET
846.66MMarket Cap-1.14P/E (TTM)

Ginkgo Bioworks Key Stats

Ginkgo Bioworks Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 44.243M--
--2024/Q4-- / 44.428M--
Nov 12, 20242024/Q389.046M / 44.986M--
Aug 8, 20242024/Q256.206M / 43.038M--
--2024/Q137.944M / 46.040M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 44.243M--
--2024/Q4-- / 44.428M--
Nov 12, 20242024/Q389.046M / 44.986M--
Aug 8, 20242024/Q256.206M / 43.038M--
--2024/Q137.944M / 46.040M--

Unlock Free Earnings Estimates

Ginkgo Bioworks Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 15, 2025

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

No Data